A retrospective study on clozapine-induced blood dyscrasias in the first 20 weeks of therapy
CZP treatment resulted in more blood disorders than TA or AA treatments. While blood abnormalities were common with CZP, severe neutropenia was rare. Certain blood changes were linked to better treatment outcomes. Therefore, regular blood monitoring is recommended to optimize treatment effectiveness and manage side effects.
Authors
- Ali Ahsan Mufti (ORCID: https://orcid.org/0009-0005-3419-6034)
- Dieter Deforce (ORCID: https://orcid.org/0000-0002-0635-661X)
- Yannick Gansemans (ORCID: https://orcid.org/0000-0001-5018-044X)
- Filip Van Nieuwerburgh (ORCID: https://orcid.org/0000-0001-8815-5485)
- Mohsin Ali (ORCID: https://orcid.org/0000-0001-8816-9529)
- Abdur Razaq
- H Ali
Institutions
- Khyber Medical University (PK)
- Lady Reading Hospital (PK)
- Ghent University (BE)
Publication Details
- Journal
- Journal of Psychiatric Research
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1016/j.jpsychires.2025.09.081
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Higher Education Commision, Pakistan